Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

Table 13.

NOAC use in frail patients

graphic file with name euab065f26.jpg

The ‘Canadian Study of Health and Aging’ (CHSA) Clinical Frailty Scale, based on comprehensive geriatric assessment including structured interview (http://www.csha.ca and Ref.338).

The decision to anticoagulate frail patients depends on multiple aspects (see text for details). While fit or mild frailty per se generally does not pose a problem (green), severe frailty and terminal illness typically indicate a contraindication to anticoagulation (red).